Molecular Infusions - Ownership and Business Overview

Life ScienceCompany

Molecular Infusions Ownership

Who owns Molecular Infusions?

Molecular Infusions is owned by Surterra Holdings. It was acquired on June 25, 2019.

Molecular Infusions Business Overview

Where is Molecular Infusions headquartered?

Molecular Infusions is headquartered in Los Angeles, California.

What sector is Molecular Infusions in?

Molecular Infusions is a life science company.

When was Molecular Infusions founded?

Molecular Infusions was founded in 2016.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 245 acquisitions of life science companies in 2019, including 40 acquisitions by private equity firms, and 205 by strategics.

Molecular Infusions LLC

Los Angeles, California
United States,
www.molecularinfusions.com

Molecular Infusions LLC is a biopharmaceutical company based in Massachusetts committed to improving lives by advancing cannabis therapies through the deployment of proprietary technologies, scientific rigor, and results-driven innovation. Molecular Infusions was founded in 2016 and is based in Los Angeles, California.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.